Michael B. Otteneder

1.3k total citations
33 papers, 859 citations indexed

About

Michael B. Otteneder is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Michael B. Otteneder has authored 33 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cancer Research. Recurrent topics in Michael B. Otteneder's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Protein purification and stability (8 papers) and DNA Repair Mechanisms (6 papers). Michael B. Otteneder is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Protein purification and stability (8 papers) and DNA Repair Mechanisms (6 papers). Michael B. Otteneder collaborates with scholars based in Switzerland, United States and Germany. Michael B. Otteneder's co-authors include Werner K. Lutz, Lawrence J. Marnett, Sven Kronenberg, Björn Jacobsen, Annika Herrmann, John P. Plastaras, Ben‐Fillippo Krippendorff, James N. Riggins, Hans Peter Grimm and Henrik E. Poulsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Chemistry.

In The Last Decade

Michael B. Otteneder

33 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael B. Otteneder Switzerland 17 417 209 174 100 97 33 859
Daniel Tamae United States 19 532 1.3× 143 0.7× 267 1.5× 148 1.5× 55 0.6× 24 1.1k
Ryan E. Pavlovicz United States 15 766 1.8× 42 0.2× 115 0.7× 69 0.7× 55 0.6× 24 1.3k
D.R. Raphael United States 12 617 1.5× 141 0.7× 51 0.3× 144 1.4× 84 0.9× 20 1.0k
Antonella Borrelli Italy 18 901 2.2× 68 0.3× 124 0.7× 163 1.6× 173 1.8× 33 1.4k
Mary T. Walsh United States 24 944 2.3× 106 0.5× 116 0.7× 137 1.4× 235 2.4× 43 1.8k
Hans Luecke United States 18 573 1.4× 85 0.4× 165 0.9× 217 2.2× 128 1.3× 22 1.2k
Yan Guan China 16 598 1.4× 35 0.2× 111 0.6× 94 0.9× 80 0.8× 26 1.0k
Jason Nowak United States 15 557 1.3× 34 0.2× 95 0.5× 165 1.6× 74 0.8× 20 1.1k
Jörg Fahrer Germany 26 1.0k 2.5× 124 0.6× 313 1.8× 519 5.2× 181 1.9× 64 1.8k
Huw M. Nash United States 16 1.4k 3.4× 85 0.4× 249 1.4× 128 1.3× 33 0.3× 20 1.6k

Countries citing papers authored by Michael B. Otteneder

Since Specialization
Citations

This map shows the geographic impact of Michael B. Otteneder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Otteneder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Otteneder more than expected).

Fields of papers citing papers by Michael B. Otteneder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael B. Otteneder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Otteneder. The network helps show where Michael B. Otteneder may publish in the future.

Co-authorship network of co-authors of Michael B. Otteneder

This figure shows the co-authorship network connecting the top 25 collaborators of Michael B. Otteneder. A scholar is included among the top collaborators of Michael B. Otteneder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael B. Otteneder. Michael B. Otteneder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwalie, Petra, Emma Bell, Désirée von Tell, et al.. (2025). Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine release. Molecular Therapy — Methods & Clinical Development. 33(3). 101551–101551. 1 indexed citations
2.
Sladojevich, Filippo, et al.. (2024). A Brief Review of Radiolabelling Nucleic Acid‐Based Molecules for Tracking and Monitoring. Journal of Labelled Compounds and Radiopharmaceuticals. 67(12-13). 410–424. 3 indexed citations
3.
Walz, Antje‐Christine, et al.. (2022). Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration. Frontiers in Pharmacology. 13. 958543–958543. 6 indexed citations
4.
Jadhav, Satyawan, et al.. (2021). Pharmacokinetics and Determination of Tumor Interstitial Distribution of a Therapeutic Monoclonal Antibody Using Large-Pore Microdialysis. Journal of Pharmaceutical Sciences. 110(8). 3061–3068. 5 indexed citations
5.
An, Bo, et al.. (2018). “Catch-and-Release” Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer. Journal of Pharmacology and Experimental Therapeutics. 366(1). 205–219. 14 indexed citations
6.
Grimm, Hans Peter, et al.. (2017). Quantification of IgG monoclonal antibody clearance in tissues. mAbs. 9(6). 1007–1015. 54 indexed citations
7.
8.
Wilkinson, D., Mingguang Li, Lisa Wright, et al.. (2017). Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro–In Vivo Comparisons. The AAPS Journal. 19(4). 1163–1174. 13 indexed citations
9.
Jadhav, Satyawan, et al.. (2017). Tissue Distribution of a Therapeutic Monoclonal Antibody Determined by Large Pore Microdialysis. Journal of Pharmaceutical Sciences. 106(9). 2853–2859. 31 indexed citations
10.
Kratochwil, Nicole A., Russell G. Jones, Claudia Suenderhauf, et al.. (2016). Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach. Pharmaceutical Research. 33(10). 2565–2579. 17 indexed citations
11.
Poirier, Agnès, Sara Belli, Christoph Funk, et al.. (2012). Role of the Intestinal Peptide Transporter PEPT1 in Oseltamivir Absorption: In Vitro and In Vivo Studies. Drug Metabolism and Disposition. 40(8). 1556–1565. 14 indexed citations
12.
Anselm, Lilli, David W. Banner, Jörg Benz, et al.. (2010). Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a clinical candidate. Bioorganic & Medicinal Chemistry Letters. 20(17). 5313–5319. 31 indexed citations
13.
Peters, Jens‐Uwe, Henrietta Dehmlow, Uwe Grether, et al.. (2010). Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity. Bioorganic & Medicinal Chemistry Letters. 20(18). 5426–5430. 11 indexed citations
14.
Freiberg, Christoph, Jens Pohlmann, Peter G. Nell, et al.. (2006). Novel Bacterial Acetyl Coenzyme A Carboxylase Inhibitors with Antibiotic Efficacy In Vivo. Antimicrobial Agents and Chemotherapy. 50(8). 2707–2712. 49 indexed citations
15.
16.
Otteneder, Michael B., J. Scott Daniels, Markus Voehler, & Lawrence J. Marnett. (2003). Development of a method for determination of the malondialdehyde–deoxyguanosine adduct in urine using liquid chromatography–tandem mass spectrometry. Analytical Biochemistry. 315(2). 147–151. 16 indexed citations
17.
Otteneder, Michael B., Ursula Lutz, & Werner K. Lutz. (2002). DNA adducts of styrene-7,8-oxide in target and non-target organs for tumor induction in rat and mouse after repeated inhalation exposure to styrene. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 500(1-2). 111–116. 13 indexed citations
18.
Otteneder, Michael B. & Werner K. Lutz. (1999). Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 424(1-2). 237–247. 100 indexed citations
19.
Otteneder, Michael B., Erwin Eder, & Werner K. Lutz. (1998). 32P-Postlabeling Analysis of DNA Adducts of Styrene 7,8-Oxide at the O6-Position of Guanine. Chemical Research in Toxicology. 12(1). 93–99. 16 indexed citations
20.
Eder, Erwin, et al.. (1997). Assessment of the Tumor-Initiating Potential of α,β-Unsaturated Carbonyl Compounds by 32P Postlabeling Quantification of DNA Adducts In Vivo. Recent results in cancer research. 143. 65–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Tamae Breakdown of academic impact, for papers by Ryan E. Pavlovicz Breakdown of academic impact, for papers by D.R. Raphael Breakdown of academic impact, for papers by Antonella Borrelli Breakdown of academic impact, for papers by Mary T. Walsh Breakdown of academic impact, for papers by Hans Luecke Breakdown of academic impact, for papers by Yan Guan Breakdown of academic impact, for papers by Jason Nowak Breakdown of academic impact, for papers by Jörg Fahrer Breakdown of academic impact, for papers by Huw M. Nash
Rankless by CCL
2026